Evaluation of the Antimicrobial Activity of ZnO Nanoparticles against Enterotoxigenic Staphylococcus aureus

Area of Science:

• Nanotechnology
• Microbiology
• Materials Science

Background:

• Staphylococcus aureus (S. aureus) is a major cause of bacterial infections, with antibiotic resistance posing a significant global health challenge.
• Metal nanoparticles and their oxides are being explored as novel antimicrobial agents to combat antibiotic-resistant bacteria.

Purpose of the Study:

• To investigate the antibacterial efficacy of zinc oxide nanoparticles (ZnO NPs) against enterotoxigenic S. aureus.
• To evaluate the impact of ZnO NPs on S. aureus growth, enterotoxin production, gene expression, and cell morphology.

Main Methods:

• In vitro antibacterial activity assessed using agar diffusion tests and minimum inhibitory concentration (MIC) determination.
• Bacterial growth reduction quantified, and enterotoxin A levels measured via ELISA.
• Gene expression analysis using PCR (targeting sea and nuc genes) and morphological changes observed using scanning electron microscopy (SEM).

Main Results:

• ZnO NPs demonstrated significant zones of inhibition and reduced bacterial counts, with a 98.99% growth reduction observed with 20 nm ZnO NPs at 10 mM.
• MIC values varied based on ZnO NP size and bacterial concentration, ranging from 2.5 to 5 mM.
• ELISA and PCR results confirmed a significant decrease in enterotoxin A and disruption of the sea gene, respectively, with no effect on the nuc gene. SEM revealed morphological damage to bacterial cells.

Conclusions:

• ZnO NPs exhibit potent antibacterial properties against S. aureus, effectively inhibiting growth, reducing enterotoxin A, and damaging bacterial cells.
• The observed effects on the sea gene suggest a mechanism involving gene expression modulation.
• ZnO NPs represent a promising alternative strategy to combat antibiotic-resistant S. aureus infections.